{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T14:24:01Z","timestamp":1795011841989,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n              <\/jats:sec><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Brain metastases from sarcomatous lesions pose a management challenge owing to their rarity and the histopathological heterogeneity. Prognostic indices such as the Graded Prognostic Assessment (GPA) index have been developed for several primary tumour types presenting with brain metastases (e.g. lung, breast, melanoma), tailored to the specifics of different primary histologies and molecular profiles. Thus far, a prognostic index to direct treatment decisions is lacking for adult sarcoma patients with brain metastases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a multicentre analysis of a national group of expert sarcoma tertiary centres (French Sarcoma Group, GSF-GETO) with the participation of one Canadian and one Swiss centre. The study cohort included adult patients with a diagnosis of a bone or soft tissue sarcoma presenting parenchymal or meningeal brain metastases, managed between January 1992 and March 2012. We assessed the validity of the original GPA index in this patient population and developed a disease-specific Sarcoma-GPA index.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The original GPA index is not prognostic for sarcoma brain metastasis patients. We have developed a dedicated Sarcoma-GPA index that identifies a sub-group of patients with particularly favourable prognosis based on histology, number of brain lesions and performance status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The Sarcoma-GPA index provides a novel tool for sarcoma oncologists to guide clinical decision-making and outcomes research.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-020-6548-6","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T12:02:34Z","timestamp":1581508954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)"],"prefix":"10.1186","volume":"20","author":[{"given":"Anna","family":"Patrikidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Chaigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Isambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Kitikidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Shanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Malivoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryline","family":"Laigre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques-Olivier","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Moureau-Zabotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Bompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Piperno-Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Alcindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Guillemet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Duffaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"H\u00fcgli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Le Pechoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dhermain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Sperduto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Le Cesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,12]]},"reference":[{"issue":"1","key":"6548_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3171\/2008.4.17505","volume":"110","author":"BD Fox","year":"2009","unstructured":"Fox BD, Patel A, Suki D, Rao G. Surgical management of metastatic sarcoma to the brain. J Neurosurg. 2009;110(1):181\u20136.","journal-title":"J Neurosurg"},{"issue":"3","key":"6548_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11060-009-0085-0","volume":"98","author":"M Salvati","year":"2010","unstructured":"Salvati M, D\u2019Elia A, Frati A, Santoro A. Sarcoma metastatic to the brain: a series of 35 cases and considerations from 27 years of experience. J Neuro-Oncol. 2010;98(3):373\u20137.","journal-title":"J Neuro-Oncol"},{"issue":"10","key":"6548_CR3","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1002\/cncr.10554","volume":"94","author":"NJ Espat","year":"2002","unstructured":"Espat NJ, Bilsky M, Lewis JJ, Leung D, Brennan MF. Soft tissue sarcoma brain metastases. Prevalence in a cohort of 3829 patients. Cancer. 2002;94(10):2706\u201311.","journal-title":"Cancer"},{"key":"6548_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","volume":"37","author":"L Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6548_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0360-3016(00)00547-2","volume":"47","author":"L Gaspar","year":"2000","unstructured":"Gaspar L, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:1001\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6548_CR6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0360-3016(99)00549-0","volume":"46","author":"E Weltman","year":"2000","unstructured":"Weltman E, Salvajoli JV, Brandt RA, de Morais HR, Prisco FE, Cruz JC, et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys. 2000;46:1155\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6548_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijrobp.2004.02.017","volume":"60","author":"J Lorenzoni","year":"2004","unstructured":"Lorenzoni J, Devriendt D, Massager N, David P, Ruiz S, Vanderlinden B, et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys. 2004;60:218\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"6548_CR8","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","volume":"170","author":"PW Sperduto","year":"2008","unstructured":"Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys. 2008;170(2):510\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6548_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","volume":"77","author":"PW Sperduto","year":"2010","unstructured":"Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2010;77:655\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"6548_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","volume":"30","author":"PW Sperduto","year":"2012","unstructured":"Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis- specific tool to estimate survival for patients with brain metastases. J Clin Oncol. 2012;30(4):419\u201326.","journal-title":"J Clin Oncol"},{"issue":"5","key":"6548_CR11","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.ijrobp.2011.02.027","volume":"82","author":"PW Sperduto","year":"2012","unstructured":"Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, et al. The effect of tumor subtype on survival and the graded prognostic assessment (GPA) for patients with breast cancer and brain metastases. Int J Radiat Oncol Biol Phys. 2012;82(5):2111\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6548_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11060-013-1083-9","volume":"112","author":"PW Sperduto","year":"2013","unstructured":"Sperduto PW, Kased N, Roberge D, Chao ST, Shanley R, Luo X, et al. The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neuro-Oncol. 2013;112:467\u201372.","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"6548_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","volume":"3","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Young TJ, Beal K, Pan H, Brown PD, Bangdiwala A, et al. Estimating survival in patients with lung Cancer and brain metastases. An update of the graded prognostic assessment for lung Cancer using molecular markers (lung-molGPA). JAMA Oncol. 2017;3(6):827\u201331.","journal-title":"JAMA Oncol"},{"issue":"4","key":"6548_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ijrobp.2017.06.2454","volume":"99","author":"PW Sperduto","year":"2017","unstructured":"Sperduto PW, Jiang W, Brown PD, Brunstein S, Sneed P, Wattson DA, et al. Estimating survival in melanoma patients with brain metastases. An update of the graded prognostic assessment for melanoma using molecular markers (melanoma-molGPA). Int J Radiat Oncol Biol Phys. 2017;99(4):812\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"6548_CR15","first-page":"22790","volume":"8","author":"Q Wu","year":"2017","unstructured":"Wu Q, Li J, Zhu S, Wu J, Chen C, Liu Q, et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget. 2017;8(17):22790\u20137996.","journal-title":"Oncotarget"},{"key":"6548_CR16","doi-asserted-by":"publisher","first-page":"45411","DOI":"10.1038\/srep45411","volume":"7","author":"Y Gong","year":"2017","unstructured":"Gong Y, Liu YR, Ji P, Hu X, Shao ZM. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Sci Rep. 2017;7:45411\u201320.","journal-title":"Sci Rep"},{"issue":"8","key":"6548_CR17","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1634\/theoncologist.2017-0136","volume":"23","author":"L Chaigneau","year":"2018","unstructured":"Chaigneau L, Patrikidou A, Ray-Coquard I, Valentin T, Linassier C, Bay JO, et al. Brain metastases from adult sarcoma: prognostic factors and impact of treatment. A retrospective analysis from the French sarcoma group (GSF\/GETO). Oncologist. 2018;23(8):948\u201355.","journal-title":"Oncologist"},{"issue":"1","key":"6548_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1200\/JCO.1997.15.1.350","volume":"15","author":"L Guillou","year":"1997","unstructured":"Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol Off J Am Soc Clin Oncol. 1997;15(1):350\u201362.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"6548_CR19","unstructured":"Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed. Geneva: WHO; 2013. IARC WHO Classification of Tumours, No 5"},{"key":"6548_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/sj.bjc.6601665","volume":"90","author":"MR van Dijk","year":"2004","unstructured":"van Dijk MR, Steyerberg EW, Stenning SP, Dusseldorp E, Habbema JDF. Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by cox regression and recursive partitioning. Br J Cancer. 2004;90:1176\u201383.","journal-title":"Br J Cancer"},{"key":"6548_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/sj.onc.1204074","volume":"20","author":"M Ladanyi","year":"2001","unstructured":"Ladanyi M, Lui MY, Antonescu CR, Krause-Boehm A, Meindl A, Argani P, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48\u201357.","journal-title":"Oncogene"},{"key":"6548_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/1097-0142(20010201)91:3<585::AID-CNCR1038>3.0.CO;2-0","volume":"91","author":"C Portera","year":"2001","unstructured":"Portera C, Ho V, Patel SR, Hunt KK, Feig BW, Respondek PM, et al. Alveolar soft part sarcoma clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001;91:585\u201391.","journal-title":"Cancer"},{"key":"6548_CR23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/0046-8177(93)90121-V","volume":"24","author":"KO Lillehei","year":"1993","unstructured":"Lillehei KO, Kleinschmidt-DeMasters B, Mitchell DH, Spector E, Kruse CA. Alveolar soft part sarcoma: an unusually long interval between presentation and brain metastasis. Hum Pathol. 1993;24:1030\u20134.","journal-title":"Hum Pathol"},{"key":"6548_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/1097-0142(19880201)61:3<593::AID-CNCR2820610329>3.0.CO;2-Z","volume":"61","author":"AJ Lewis","year":"1988","unstructured":"Lewis AJ. Sarcoma metastatic to the brain. Cancer. 1988;61:593\u2013601.","journal-title":"Cancer"},{"key":"6548_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1097-0142(19890101)63:1<1::AID-CNCR2820630102>3.0.CO;2-E","volume":"63","author":"PH Lieberman","year":"1989","unstructured":"Lieberman PH, Brennan MF, Kimmel M, Erlandson RA, Garin-Chesa P, Fiehinger BY. Alveolar soft-part sarcoma: a clinicopathologic study of half a century. Cancer. 1989;63:1\u201313.","journal-title":"Cancer"},{"key":"6548_CR26","first-page":"109","volume":"99","author":"AE Rosenbaum","year":"1971","unstructured":"Rosenbaum AE, Gabrielsen TO, Harris H, Goldberg S. Cerebral manifestations of alveolar soft-part sarcoma. Neuroradiology. 1971;99:109\u201315.","journal-title":"Neuroradiology"},{"key":"6548_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0090-3019(97)00034-7","volume":"49","author":"M Salvati","year":"1998","unstructured":"Salvati M, Cervoni L, Caruso R, Gagliardi FM, Delfini R. Sarcoma metastatic to the brain: a series of 15 cases. Surg Neurol. 1998;49:441\u20134.","journal-title":"Surg Neurol"},{"issue":"suppl; abstr 10","key":"6548_CR28","first-page":"5s","volume":"32","author":"M Hoiczyk","year":"2014","unstructured":"Hoiczyk M, Herbrik M, Grabellus F, Podleska L, P\u00f6ttgen C, Schwindenhamme B, et al. Brain metastases in sarcoma patients: Incidence and outcome. J Clin Oncol. 2014;32(suppl; abstr 10591):5s.","journal-title":"J Clin Oncol"},{"key":"6548_CR29","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/0014-2964(80)90062-6","volume":"16","author":"BM Bryant","year":"1980","unstructured":"Bryant BM, Wiltshaw E. Central nervous system involvement in sarcoma. Eur J Cancer. 1980;16:1503\u20137.","journal-title":"Eur J Cancer"},{"key":"6548_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/1097-0142(19800115)45:2<377::AID-CNCR2820450231>3.0.CO;2-5","volume":"45","author":"P Espana","year":"1980","unstructured":"Espana P, Chang P, Wiernik P. Increased incidence of brain metastases in sarcoma patients. Cancer. 1980;45:377\u201380.","journal-title":"Cancer"},{"key":"6548_CR31","first-page":"408","volume":"24","author":"B Essola","year":"2003","unstructured":"Essola B, Remmelink M, Kessler R, Scillia P, Rocmans P. L\u2019h\u00e9mangiop\u00e9ricytome pulmonaire primitif: deux nouvelles observations. Rev Med Brux. 2003;24:408\u201315.","journal-title":"Rev Med Brux"},{"key":"6548_CR32","first-page":"47","volume":"21","author":"J Braham","year":"1962","unstructured":"Braham J, Sarova-Pinchas I, Pauzner YM, Braf Z. Hemangiopericytoma of the lung with metastasis to the brain. Case report Isr Med J. 1962;21:47\u201350.","journal-title":"Case report Isr Med J"},{"key":"6548_CR33","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/ejcts\/ezt289","volume":"45","author":"N Ozeki","year":"2014","unstructured":"Ozeki N, Kawaguchi K, Taniguchi T, Yokoi K. Primary pulmonary solitary fibrous tumour with brain metastases. Eur J Cardio-Thoracic Surg. 2014;45:386\u20138.","journal-title":"Eur J Cardio-Thoracic Surg"},{"key":"6548_CR34","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.radcr.2016.10.014","volume":"12","author":"AJ Degnan","year":"2017","unstructured":"Degnan AJ, Lee KKW, Minervini MI, Borhani AA. Metastatic extrapleural malignant solitary fibrous tumor presenting with hypoglycemia (Doege-potter syndrome). Radiol Case Rep. 2017;12:113\u20139.","journal-title":"Radiol Case Rep"},{"key":"6548_CR35","doi-asserted-by":"crossref","unstructured":"White JR, Moughan J, Kim IA, Peereboom DM, De Los Santos JF, Boulter D, et al. NRG\/RTOG 1119: Phase II Randomized Study of Whole Brain Radiation Therapy\/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer: A Collaborative Study of NRG Oncology and KROG (NCT01622868). San Antonio Breast Cancer Symposium (SABCS) 2016, abstract OT1\u201304-02. https:\/\/www.sabcs.org\/Portals\/SABCS2016\/Documents\/SABCS-2016-Abstracts.pdf?v=1.","DOI":"10.1158\/1538-7445.SABCS16-OT1-04-02"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6548-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6548-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T12:34:32Z","timestamp":1613046872000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6548-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6548"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6548-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,12]]},"assertion":[{"value":"17 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the multi-institutional review board of the French Sarcoma Clinical Reference Network NETSARC (website:). Institutional ethics committee approval was also obtained by the two Principal Investigator centres (IRFC, Besan\u00e7on, France for LC and Centre Fran\u00e7ois Leclerc, Dijon, France for IN). Written informed consent was obtained from all alive study subjects. The study was performed in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}